Asthma Trial, Recruiting NCT06852911 Sponsor: Novlead Inc. Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06852911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with asthma:

  • You must be at least 18 years old (any gender)
  • You must have been formally diagnosed with bronchial asthma according to recognised international guidelines (GINA 2023)
  • You must have been experiencing breathing-related symptoms for at least 6 weeks
  • You must be a non-smoker, or must have stopped smoking more than 5 years ago

For healthy volunteers:

  • You must be at least 18 years old (any gender)
  • You must have no history of allergic diseases or long-term breathing conditions, and no notable health problems found in a check-up within the past year
  • You must not have had any illness or taken any medication in the past four weeks, and must not currently show signs of a respiratory infection
  • You must be a non-smoker, or must have stopped smoking at least 5 years ago

Who may not be able to join:

For people with asthma:

  • You have used additional asthma medicines (such as steroids) on top of quick-relief inhalers in the past 4 weeks
  • You have had a respiratory infection (such as a chest or airway infection) in the past 4 weeks
  • You are currently pregnant, breastfeeding, or menstruating
  • You are already taking part in another clinical trial
  • You have another medical or mental health condition that the trial doctor believes makes participation unsuitable

For healthy volunteers:

  • You are currently pregnant, breastfeeding, or menstruating
  • You have been taking any long-term medication
  • You are already taking part in another clinical trial
  • You have any medical or mental health condition that the trial doctor believes makes participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Novlead Inc.
Registry
ClinicalTrials.gov
Start date
12 September 2024
Est. completion
30 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Performance Assessment of FeNO Chemiluminescence Analyzer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov